B. M. Feldman

1.1k total citations
25 papers, 751 citations indexed

About

B. M. Feldman is a scholar working on Hematology, Surgery and Epidemiology. According to data from OpenAlex, B. M. Feldman has authored 25 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 5 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in B. M. Feldman's work include Hemophilia Treatment and Research (14 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Orthopaedic implants and arthroplasty (4 papers). B. M. Feldman is often cited by papers focused on Hemophilia Treatment and Research (14 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Orthopaedic implants and arthroplasty (4 papers). B. M. Feldman collaborates with scholars based in Canada, United States and Netherlands. B. M. Feldman's co-authors include Victor S. Blanchette, Rayfel Schneider, Lynne McCullough, F. Virginia Wright, Andréa S. Doria, Earl D. Silverman, Sulaiman M. Al‐Mayouf, R M Laxer, Cedric Manlhiot and Sharon Funk and has published in prestigious journals such as Journal of Thrombosis and Haemostasis, American Journal of Neuroradiology and Lara D. Veeken.

In The Last Decade

B. M. Feldman

25 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. M. Feldman Canada 13 456 176 128 118 101 25 751
S. Ota Canada 10 138 0.3× 158 0.9× 132 1.0× 57 0.5× 68 0.7× 14 476
Susan Nielsen Denmark 16 523 1.1× 107 0.6× 301 2.4× 36 0.3× 206 2.0× 43 769
Silvia Pederzoli Italy 10 376 0.8× 82 0.5× 141 1.1× 24 0.2× 250 2.5× 22 498
Rafael Rivas‐Chacon United States 8 106 0.2× 212 1.2× 182 1.4× 38 0.3× 49 0.5× 8 483
Kristen Hayward United States 10 210 0.5× 29 0.2× 96 0.8× 41 0.3× 92 0.9× 18 413
Megan L. Curran United States 13 77 0.2× 107 0.6× 151 1.2× 36 0.3× 83 0.8× 33 537
Harry L. Gewanter United States 8 86 0.2× 191 1.1× 165 1.3× 64 0.5× 56 0.6× 19 487
N. Adib United Kingdom 6 141 0.3× 35 0.2× 86 0.7× 36 0.3× 77 0.8× 8 436
Rik Joos Belgium 15 221 0.5× 53 0.3× 392 3.1× 12 0.1× 34 0.3× 29 608
L. Heijnen Netherlands 18 1.2k 2.7× 49 0.3× 46 0.4× 358 3.0× 46 0.5× 31 1.4k

Countries citing papers authored by B. M. Feldman

Since Specialization
Citations

This map shows the geographic impact of B. M. Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. M. Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. M. Feldman more than expected).

Fields of papers citing papers by B. M. Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. M. Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. M. Feldman. The network helps show where B. M. Feldman may publish in the future.

Co-authorship network of co-authors of B. M. Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of B. M. Feldman. A scholar is included among the top collaborators of B. M. Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. M. Feldman. B. M. Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Timmer, Merel A., Samantha C. Gouw, B. M. Feldman, et al.. (2017). Measuring activities and participation in persons with haemophilia: A systematic review of commonly used instruments. Haemophilia. 24(2). e33–e49. 22 indexed citations
2.
Fischer, Kathelijn, Pradeep Mathew Poonnoose, Amy L. Dunn, et al.. (2016). Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective. Haemophilia. 23(1). 11–24. 64 indexed citations
3.
Villaça, Paula Ribeiro, Victor S. Blanchette, Jorge David Aivazoglou Carneiro, et al.. (2016). Validity of the Portuguese CHO‐KLAT in Brazil. Haemophilia. 22(6). 894–897. 5 indexed citations
4.
Berg, H. Marijke van den, B. M. Feldman, Kathelijn Fischer, et al.. (2015). Assessments of outcome in haemophilia – what is the added value of QoL tools?. Haemophilia. 21(4). 430–435. 21 indexed citations
5.
Verhey, Leonard H., I. A. Ketelslegers, R. F. Neuteboom, et al.. (2013). Validation of MRI predictors of multiple sclerosis diagnosis in children with acute CNS demyelination. Multiple Sclerosis and Related Disorders. 2(3). 193–199. 8 indexed citations
6.
Verhey, Leonard H., Helen M. Branson, Suzanne Laughlin, et al.. (2013). Development of a Standardized MRI Scoring Tool for CNS Demyelination in Children. American Journal of Neuroradiology. 34(6). 1271–1277. 8 indexed citations
7.
Kraft, Jeannette, Victor S. Blanchette, Paul Babyn, et al.. (2012). Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada. Journal of Thrombosis and Haemostasis. 10(12). 2494–2502. 73 indexed citations
8.
Feldman, B. M.. (2012). Implementing musculoskeletal outcome assessments in clinical practice. Haemophilia. 18(s4). 120–124. 7 indexed citations
9.
Aviel, Yonatan Butbul, Robyn Stremler, Susanne M. Benseler, et al.. (2011). Sleep and fatigue and the relationship to pain, disease activity and quality of life in juvenile idiopathic arthritis and juvenile dermatomyositis. Lara D. Veeken. 50(11). 2051–2060. 100 indexed citations
10.
Schmeling, Heinrike, et al.. (2010). Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis. Lara D. Veeken. 50(5). 885–893. 48 indexed citations
11.
Manlhiot, Cedric, Lin Liang, Dat Tran, et al.. (2008). Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset. Lara D. Veeken. 47(4). 526–529. 41 indexed citations
12.
Feldman, B. M., Sharon Funk, Björn Lundin, et al.. (2008). Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG). Haemophilia. 14(s3). 162–169. 58 indexed citations
13.
Feldman, B. M., Louis M. Aledort, Monika Bullinger, et al.. (2007). The economics of haemophilia prophylaxis: governmental and insurer perspectives. PROCEEDINGS OF THE SECOND INTERNATIONAL PROPHYLAXIS STUDY GROUP (IPSG) SYMPOSIUM. Haemophilia. 13(6). 745–749. 15 indexed citations
14.
15.
Barrera, Manuel, Joseph Beyene, Manuel Carção, et al.. (2007). The Gap Study (GapS) interview--developing a process to determine the meaning and determinants of quality of life in children with arthritis and rheumatic disease.. PubMed. 25(3). 486–93. 6 indexed citations
16.
Feldman, B. M., Paul Babyn, Andréa S. Doria, et al.. (2005). Proceedings of the International Haemophilia Prophylaxis Study Group Meeting, November 2003, Montreal, PQ, Canada. Haemophilia. 11(1). 58–63. 8 indexed citations
17.
Carção, Manuel, Wendy J. Ungar, & B. M. Feldman. (2004). Cost–utility analysis in evaluating prophylaxis in haemophilia. Haemophilia. 10(s1). 50–57. 9 indexed citations
18.
Manco‐Johnson, M. J., H. Pettersson, Pia Petrini, et al.. (2004). Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions. Haemophilia. 10(s4). 88–93. 48 indexed citations
19.
Feldman, B. M., et al.. (2000). Distinction of quality of life, health related quality of life, and health status in children referred for rheumatologic care.. PubMed. 27(1). 226–33. 92 indexed citations
20.
Feldman, B. M., et al.. (1995). How should excess admission laboratory test utilization be curtailed? --paediatricians' preferences.. PubMed. 18(6). 502–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Ota Breakdown of academic impact, for papers by Susan Nielsen Breakdown of academic impact, for papers by Silvia Pederzoli Breakdown of academic impact, for papers by Rafael Rivas‐Chacon Breakdown of academic impact, for papers by Kristen Hayward Breakdown of academic impact, for papers by Megan L. Curran Breakdown of academic impact, for papers by Harry L. Gewanter Breakdown of academic impact, for papers by N. Adib Breakdown of academic impact, for papers by Rik Joos Breakdown of academic impact, for papers by L. Heijnen
Rankless by CCL
2026